Donald Trump’s second administration has advanced an avalanche of policy action and political pronouncements that have jolted ...

Hims & Hers believes that is where the controversy lies. “We called on the industry and said that they need to change — and ...

Donald Trump's second administration has executed significant policy changes and political announcements, following his ...

None of the 49 people detained in a raid on a makeshift nightclub in Adams County are facing criminal charges, according to ...

The stop-work order on U.S.A.I.D.-funded research has left thousands of people with experimental drugs and devices in their ...

The ad violates federal rules requiring “that advertising for prescription drugs – including compounded drugs – not be false ...

The U.S. Food and Drug Administration has approved Axsome Therapeutics' Symbravo (meloxicam and rizatriptan) for the acute ...

More details on the Canadian plan to boost security at the northern border have been released, as the country tries to navigate the Trump administration's demand to crack down on human and drug ...

The Food and Drug Administration (FDA) has approved Journavx™ (suzetrigine) for the treatment of moderate to severe acute pain in adults.

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

and U.S. Food and Drug Administration. Fink added that some exceptions would be made for communications affecting "critical health, safety, environmental, financial, or national security functions." A ...